Fenimore Christopher R. — SEC insider filings

SEC reporting owner CIK 1697422. 27 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-12-11 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)EVP Finance CFO27—30 legs · 27,140 sh · $23,966,78968

Insider filings — Fenimore Christopher R.

FiledFormIssuerReported transactionsSource
2026-11-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 6,000 @ $381.92 · Tax withholding (F): 4,243 @ $950.50 · Gift (G): 15 @ $0 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2026-08-204REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 6,283 @ $381.92 · Tax withholding (F): 4,599 @ $813.47 · Option exercise (M): 6,283 (derivative) @ $0EDGAR
2025-12-094REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 3,027 @ $0 · Tax withholding (F): 992 @ $712.94 · Grant/award (A): 14,924 (derivative) @ $0EDGAR
2024-12-184REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 491 @ $730.81EDGAR
2024-12-104REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 2,591 @ $0 · Tax withholding (F): 1,140 @ $787 · Grant/award (A): 9,979 (derivative) @ $0EDGAR
2024-08-294REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 228 @ $1,204.79 · Sale (S): 766 @ $1,205.44 · Sale (S): 200 @ $1,206.30 · Sale (S): 2,237 @ $1,204.71 · Sale (S): 928 @ $1,205.49 · Sale (S): 450 @ $1,206.15 · +4 moreEDGAR
2024-02-124REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 344 @ $950.49 · Sale (S): 487 @ $951.39 · Sale (S): 1,046 @ $952.62 · Sale (S): 1,342 @ $953.47 · Sale (S): 1,100 @ $954.57 · Sale (S): 600 @ $955EDGAR
2024-01-254REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 5,000 @ $555.67 · Tax withholding (F): 3,986 @ $948.50 · Option exercise (M): 5,000 @ $399.66 · Tax withholding (F): 3,583 @ $948.50 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2024-01-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 5,000 @ $555.67 · Tax withholding (F): 4,043 @ $912.30 · Option exercise (M): 5,000 @ $399.66 · Tax withholding (F): 3,469 @ $912.30 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-12-294REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 2,448 @ $856.71EDGAR
2023-12-264REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 456 @ $843.79 · Sale (S): 1,224 @ $844.09 · Sale (S): 250 @ $846.27EDGAR
2023-12-144REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 2,552 @ $856.71EDGAR
2023-12-124REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 474 @ $843.79 · Grant/award (A): 2,370 @ $0 · Tax withholding (F): 1,276 @ $844.09 · Tax withholding (F): 260 @ $844.09 · Grant/award (A): 8,499 (derivative) @ $0EDGAR
2023-08-254REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 7,000 @ $399.66 · Tax withholding (F): 5,198 @ $842.66 · Option exercise (M): 7,000 (derivative) @ $0EDGAR
2023-03-274REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 2,192 @ $806.47EDGAR
2023-02-074REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 5,000 @ $270.43 · Tax withholding (F): 3,286 @ $774.29 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2022-12-204REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 1,926 @ $0 · Grant/award (A): 7,111 (derivative) @ $0EDGAR
2022-12-134REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 247 @ $753.28 · Gift (G): 871 @ $0 · Gift (G): 436 @ $0 · Gift (G): 435 @ $0EDGAR
2022-10-074REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,844 @ $749EDGAR
2022-10-054REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 3,346 @ $724EDGAR
2022-04-114REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,450 @ $555.67 · Tax withholding (F): 2,155 @ $736.21 · Option exercise (M): 5,000 @ $270.43 · Tax withholding (F): 3,451 @ $736.21 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 2,450 (derivative) @ $0EDGAR
2022-04-014REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,000 @ $555.67 · Tax withholding (F): 1,797 @ $700.99 · Option exercise (M): 10,000 @ $270.43 · Tax withholding (F): 6,857 @ $700.99 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2021-12-144REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 270 @ $664.34EDGAR
2021-12-104REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 1,859 @ $0 · Grant/award (A): 7,941 (derivative) @ $0EDGAR
2021-08-254/AREGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 8,719 @ $664.85EDGAR
2021-08-244REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 13,500 @ $179.13 · Sale (S): 4,576 @ $655 · Sale (S): 9 @ $659.33 · Sale (S): 23 @ $660.33 · Sale (S): 88 @ $661.89 · Sale (S): 1 @ $662.78 · +3 moreEDGAR
2020-12-114REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 969 @ $0 · Grant/award (A): 1,750 @ $0 · Gift (G): 50 @ $0 · Gift (G): 25 @ $0 · Gift (G): 25 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1697422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs